AbbVie Inc (ABBV)
178.54
+0.66
(+0.37%)
USD |
NYSE |
Mar 18, 16:00
178.49
-0.04
(-0.03%)
After-Hours: 20:00
AbbVie Total Return Level: 281.56 for March 15, 2024
Total Return Level Chart
Historical Total Return Level Data
Date | Value |
---|---|
March 15, 2024 | 281.56 |
March 14, 2024 | 286.82 |
March 13, 2024 | 284.69 |
March 12, 2024 | 286.37 |
March 11, 2024 | 284.33 |
March 08, 2024 | 283.10 |
March 07, 2024 | 285.82 |
March 06, 2024 | 286.59 |
March 05, 2024 | 283.59 |
March 04, 2024 | 280.25 |
March 01, 2024 | 283.19 |
February 29, 2024 | 278.66 |
February 28, 2024 | 281.75 |
February 27, 2024 | 283.32 |
February 26, 2024 | 283.03 |
February 23, 2024 | 281.89 |
February 22, 2024 | 279.77 |
February 21, 2024 | 277.22 |
February 20, 2024 | 278.19 |
February 16, 2024 | 280.94 |
February 15, 2024 | 279.52 |
February 14, 2024 | 276.08 |
February 13, 2024 | 274.30 |
February 12, 2024 | 273.95 |
February 09, 2024 | 275.55 |
Date | Value |
---|---|
February 08, 2024 | 276.67 |
February 07, 2024 | 277.02 |
February 06, 2024 | 274.30 |
February 05, 2024 | 271.08 |
February 02, 2024 | 266.98 |
February 01, 2024 | 265.27 |
January 31, 2024 | 260.22 |
January 30, 2024 | 261.05 |
January 29, 2024 | 259.45 |
January 26, 2024 | 260.22 |
January 25, 2024 | 261.38 |
January 24, 2024 | 259.94 |
January 23, 2024 | 265.13 |
January 22, 2024 | 261.79 |
January 19, 2024 | 260.81 |
January 18, 2024 | 258.48 |
January 17, 2024 | 256.49 |
January 16, 2024 | 255.60 |
January 12, 2024 | 257.06 |
January 11, 2024 | 256.79 |
January 10, 2024 | 258.53 |
January 09, 2024 | 254.49 |
January 08, 2024 | 253.11 |
January 05, 2024 | 254.22 |
January 04, 2024 | 253.15 |
Total Return Level Definition
The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.
Total Return Level Range, Past 5 Years
81.47
Minimum
Aug 15 2019
286.82
Maximum
Mar 14 2024
173.40
Average
165.56
Median
Total Return Level Benchmarks
Amgen Inc | 373.79 |
Gilead Sciences Inc | 100.23 |
Immunogen Inc (DELISTED) | -- |
Johnson & Johnson | 507.94 |
Eli Lilly and Co | 2170.83 |